Scientists track lifespan of transfused blood in sickle cell kids
NCT ID NCT04426591
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how long donor red blood cells survive in children with sickle cell disease who get regular blood transfusions. Researchers labeled a small part of the transfused blood with a harmless marker and tracked it over time. The goal was to better understand why some transfusions may not work as well as expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Childrens Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
-
Grady Health System
Atlanta, Georgia, 30322, United States
-
Hughes Spalding Children's Hospital
Atlanta, Georgia, 30303, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple screening test at birth save thousands of children with sickle cell disease?
- Can Eye-Tracking reveal hidden brain risks in babies with sickle cell disease?
- Gene therapy aims to free patients from lifelong blood transfusions
- Can a peer coach help young people take control of their chronic illness?
- Could a stronger dose of an old drug protect children with sickle cell from organ damage?
- Gene editing could cure sickle cell by boosting fetal hemoglobin